• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成低毒P-选择素抑制剂的策略:药效团建模、虚拟筛选和反药效团筛选以去除有毒命中物。

Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.

作者信息

Ananthula Ravi Shekar, Ravikumar Muttineni, Pramod A B, Madala Kishore Kumar, Mahmood S K

机构信息

BioCampus, GVKBIO S-1, Phase-1, Technocrats Industrial Estate, Balanagar, Hyderabad, Andhra Pradesh 500037, India.

出版信息

J Mol Graph Model. 2008 Nov;27(4):546-57. doi: 10.1016/j.jmgm.2008.09.007. Epub 2008 Sep 20.

DOI:10.1016/j.jmgm.2008.09.007
PMID:18993099
Abstract

This paper describes the generation of ligand-based as well as structure-based models and virtual screening of less toxic P-selectin receptor inhibitors. Ligand-based model, 3D-pharmacophore was generated using 27 quinoline salicylic acid compounds and is used to retrieve the actives of P-selectin. This model contains three hydrogen bond acceptors (HBA), two ring aromatics (RA) and one hydrophobic feature (HY). To remove the toxic hits from the screened molecules, a counter pharmacophore model was generated using inhibitors of dihydrooratate dehydrogenase (DHOD), an important enzyme involved in nucleic acid synthesis, whose inhibition leads to toxic effects. Structure-based models were generated by docking and scoring of inhibitors against P-selectin receptor, to remove the false positives committed by pharmacophore screening. The combination of these ligand-based and structure-based virtual screening models were used to screen a commercial database containing 538,000 compounds.

摘要

本文描述了基于配体和基于结构的模型的生成以及低毒P-选择素受体抑制剂的虚拟筛选。基于配体的模型,即三维药效团,是使用27种喹啉水杨酸化合物生成的,并用于检索P-选择素的活性物质。该模型包含三个氢键受体(HBA)、两个环芳烃(RA)和一个疏水特征(HY)。为了从筛选出的分子中去除有毒的命中物,使用二氢乳清酸脱氢酶(DHOD)抑制剂生成了一个反药效团模型,DHOD是参与核酸合成的一种重要酶,其抑制会导致毒性作用。通过将抑制剂与P-选择素受体进行对接和评分生成基于结构的模型,以去除药效团筛选产生的假阳性。这些基于配体和基于结构的虚拟筛选模型相结合,用于筛选一个包含538,000种化合物的商业数据库。

相似文献

1
Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.生成低毒P-选择素抑制剂的策略:药效团建模、虚拟筛选和反药效团筛选以去除有毒命中物。
J Mol Graph Model. 2008 Nov;27(4):546-57. doi: 10.1016/j.jmgm.2008.09.007. Epub 2008 Sep 20.
2
Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.基于药效团和基于结构的虚拟筛选模型对单胺氧化酶-B(MAO-B)选择性抑制剂进行基于知识的识别。
Eur J Med Chem. 2009 Sep;44(9):3584-90. doi: 10.1016/j.ejmech.2009.02.031. Epub 2009 Mar 11.
3
A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.基于对接和药效团模型的胸苷一磷酸激酶抑制剂作为抗结核药物的虚拟筛选方法。
J Chem Inf Model. 2005 Jul-Aug;45(4):1101-8. doi: 10.1021/ci050064z.
4
The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.新型血管内皮生长因子受体酪氨酸激酶抑制剂的发现:药效团建模、虚拟筛选与对接研究
Chem Biol Drug Des. 2007 Mar;69(3):204-11. doi: 10.1111/j.1747-0285.2007.00488.x.
5
3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.基于 3D QSAR 药效团的虚拟筛选和分子对接鉴定潜在 HSP90 抑制剂。
Eur J Med Chem. 2010 Jun;45(6):2132-40. doi: 10.1016/j.ejmech.2010.01.016. Epub 2010 Feb 4.
6
Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.针对结核分枝杆菌二氢叶酸还原酶的虚拟筛选:使用结构相互作用指纹进行化合物优先级排序的建议工作流程。
J Mol Graph Model. 2008 Nov;27(4):476-88. doi: 10.1016/j.jmgm.2008.08.005. Epub 2008 Aug 28.
7
Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.多种药效团模型与分子对接相结合:有效鉴定具有高结构多样性的新型 PDE4 抑制剂的可靠方法。
J Chem Inf Model. 2010 Apr 26;50(4):615-25. doi: 10.1021/ci9004173.
8
Identification of potent urease inhibitors via ligand- and structure-based virtual screening and in vitro assays.通过配体和基于结构的虚拟筛选及体外检测鉴定有效的脲酶抑制剂。
J Mol Graph Model. 2010 Jun;28(8):792-8. doi: 10.1016/j.jmgm.2010.02.004. Epub 2010 Feb 17.
9
Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors.基于药效团的 Hsp90 抑制剂虚拟筛选和对接研究。
SAR QSAR Environ Res. 2010 Jul;21(5-6):445-62. doi: 10.1080/1062936X.2010.501817.
10
Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads.药效团建模和虚拟筛选研究以设计一些潜在的组蛋白脱乙酰酶抑制剂作为新的先导化合物。
J Mol Graph Model. 2008 Feb;26(6):935-46. doi: 10.1016/j.jmgm.2007.07.002. Epub 2007 Jul 12.

引用本文的文献

1
Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.基于结构和形状互补的药效团模型在新型细胞周期检查点激酶 1 抑制剂发现中的应用。
J Mol Model. 2010 Jul;16(7):1195-204. doi: 10.1007/s00894-009-0630-y. Epub 2009 Dec 18.